Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

6th Annual RAS-Targeted Drug Development Summit

Evvnt Promotion / evvnt
-
24.09.2024 - 26.09.2024  Hilton Boston Park Plaza, 50 Park Plaza, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 4:45 PM
 
Temi della conferenza
Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology

With tumor and patient heterogeneity, the quest to target the remaining RAS mutants continues, and now more than ever, we are witnessing this industry make great strides in utilizing novel modalities and elucidating mechanisms of resistance.
Professional congress organizer (PCO)
Hanson Wade Group
Annotazioni
URL:
Brochure: https://go.evvnt.com/2464057-3?pid=4832

Speakers: Ahmadur Rahman, Senior Clinical Director and Clinical Science Lead, Global Oncology Research and Development, Roche, and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2464057-2?pid=4832
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 5097.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Center of ExcellenceAlumni Club Medizinische Universität WienÖsterreichisches Rotes KreuzSwiss Tropical and Public Health InstitutenewTreeCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärzte der Welt